- Establishment, law & taxes
- Research & development
The research premium continues to be a success factor for Austria’s competitiveness as a business location. Companies can apply for the 14% research premium for research and development expenditures. This research premium was increased from 12% to 14% in 2018. Since then, a significant expansion in corporate research activities has been evident.
In 2017, applications for € 713 million were submitted, compared to about € 758 million in 2019 and 2020. The € 1 billion threshold was surpassed in 2021. In 2022, companies applied for a bonus of € 1.8 billion for more than 9,100 research projects. Approx. 80% of the firms applying for the research premium are small and medium-sized enterprises. The Tax Amendment Act 2022 resulted in the implementation of important improvements for the benefit of companies, including the ability to issue partial assessment notices and the assessment base expanded to include an “entrepreneur’s wage”
The research premium is an important business location factor and attracts innovative companies to Austria. In international competition, attractive conditions are necessary for research and development activities as a means of further enhancing the innovative strength of the national economy. The new regulations also increasingly enable startups and SMEs which conduct research to benefit from the research premium.
Today more than one million engines and ten million core engine components already leave the assembly lines of the Austrian BMW plant in Steyr, Upper Austria each year.
The University Hospital Vienna and its university clinics jointly managed by the Medical University of Vienna have been ranked 30th in the latest ranking of the world's 250 best hospitals evaluated by the American news magazine Newsweek and the data provider Statista.